Clinical trial
DelIVery for Pulmonary Arterial Hypertension (PAH) Clinical Study
NCT01321073 is registered in ClinicalTrials.gov with Medtronic Cardiac Rhythm and Heart Failure as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DelIVery for Pulmonary Arterial Hypertension (PAH) Clinical Study
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- June 30, 2011
- Completion date
- December 31, 2032
- Enrollment
- 64 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.